{"title":"Deprescribing Benzodiazepines, Z-Drugs, and Stimulants","authors":"Swapnil Gupta, Rebecca Miller, J. Cahill","doi":"10.1093/MED/9780190654818.003.0011","DOIUrl":null,"url":null,"abstract":"This chapter addresses the considerations particular to deprescribing benzodiazepines and stimulant medications. Included are considerations around deprescribing those medications that a patient may be invested in taking either because the medications provide immediate relief or because they can improve occupational functioning in the short-term. Addiction and problem use (due to rewarding effects) of psychotropic medications are beyond the scope of this book and are amply addressed elsewhere. Addressed are psychoeducation needs, the acknowledgment of how much relief the medications bring, and the recognition of how severe and prolonged withdrawal symptoms can be. Accounts from patients experiencing prolonged withdrawal are included as well as suggestions around tapering speed and flexibility adapted to the patient’s response and supported by other measures such as cognitive behavioral therapy (CBT) for anxiety, CBT for insomnia, and connection with support groups.","PeriodicalId":296046,"journal":{"name":"Deprescribing in Psychiatry","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Deprescribing in Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/MED/9780190654818.003.0011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This chapter addresses the considerations particular to deprescribing benzodiazepines and stimulant medications. Included are considerations around deprescribing those medications that a patient may be invested in taking either because the medications provide immediate relief or because they can improve occupational functioning in the short-term. Addiction and problem use (due to rewarding effects) of psychotropic medications are beyond the scope of this book and are amply addressed elsewhere. Addressed are psychoeducation needs, the acknowledgment of how much relief the medications bring, and the recognition of how severe and prolonged withdrawal symptoms can be. Accounts from patients experiencing prolonged withdrawal are included as well as suggestions around tapering speed and flexibility adapted to the patient’s response and supported by other measures such as cognitive behavioral therapy (CBT) for anxiety, CBT for insomnia, and connection with support groups.